Last updated on October 2016

A Multi-center Randomized Double-blind Active-controlled Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia


Brief description of study

A Multi-center, Randomized, double-blind, active-controlled, phase 3 trial to evaluate the safety and efficacy of Metformin/Atorvastatin in subjects with Type II Diabetes and dyslipidemia.

Clinical Study Identifier: NCT02947620

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Daewoong Clinical

Samsung Medical Center
Seoul, Korea, Republic of
  Connect »